Conversely, another study measured soluble TDP-43 in serum using a more sensible system, the Simoa® TDP-43 kit, reporting slightly decreased TDP-43 levels in FTD-TDP compared to FTD-tau and healthy controls [56]. The gene discussed is MAPT; the disease is frontotemporal dementia.